ClinicalTrials.Veeva

Menu

New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)

D

Dr. S.S. Michel Clinic

Status

Completed

Conditions

Sickle Cell Retinopathy

Treatments

Device: Optical Coherence Tomography Angiography

Study type

Observational

Funder types

Other

Identifiers

NCT03068702
Optical Coherence Tomography

Details and patient eligibility

About

Sickle cell maculopathy was sparingly mentioned in the literature before despite the fact that sickle cell disease or sickle cell trait is common in people of many areas of the world. This study shows that OCTA is a very valuable, non invasive, office procedure that may well be used in diagnosing this disease.

Full description

this is a clinical study of two African Canadian patients that were diagnosed with sickle cell trait. I used OCTA to show macular vascular occlusions that usually happen with this disease.

Enrollment

2 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: people with sickle cell trait or sickle cell disease -

Exclusion Criteria:

Trial design

2 participants in 1 patient group

African Canadians
Description:
African Canadians with sickle cell disease maculopathy diagnosed by OCTA.
Treatment:
Device: Optical Coherence Tomography Angiography

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems